Specialists in the MM field are in the enviable position of having lots of different treatment options available – the challenge is how to integrate these into the… read more.
Multiple myeloma is unique amongst cancers in that the diagnosis is made by the clinician, not the pathologist. The pathologist merely states that the patient has a clonal… read more.
IMW President, Professor Antonio Palumbo (Torino, Italy) gives his highlights, along with Dr Noopar Raje (Boston, USA) , Professor Faith Davies, (Little Rock, USA) and Professor Paul Richardson (Boston, USA).
Vijayveer Bonthapally et al, Cambridge, MA, USA / by Maria Dalby. AETHERA is a randomised, placebo-controlled phase III study to evaluate whether consolidation treatment with brentuximab vedotin can… read more.
Zeinab Ali Abou Yehia et al, Houston, TX, USA / by Maria Dalby. PET-CT scans appear to be more sensitive than bone marrow biopsies for detecting bone marrow… read more.
John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby. Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.
Dr Andrew Davies, Southampton, UK, Professor John Radford, The University of Manchester, UK, Professor Peter Johnson, Southampton University, UK, Dr Karl Peggs, University College Hospital, London, Professor Stephen… read more.
Interview with Professor Joseph Connors, Vancouver, BC, Canada, who spoke for the motion in this key debate at ICML 2015. Interview by Esther Drain.
by Christine Clark: The National Cancer Information Network (NCIN) was established to drive change and improve cancer outcomes. Analyses show large variations in practices and outcomes some of… read more.
Dr Graham Collins from the Oxford Cancer and Haematology Centre, Oxford, UK.
Advertisment